This may be the new way to cure depression and inflammation 👀🙏🏽
24 Nov 2024 · 1 min

0:57
In this segment, the speakers discuss emerging research that links chronic inflammation to major depressive disorder and present evidence from peer‑reviewed studies that reducing inflammation can alleviate depressive symptoms. They introduce EPA (eicosapentaenoic acid), an omega‑3 fatty acid, as a supplement that not only supports cardiovascular health and cell‑membrane formation but also possesses distinct anti‑inflammatory properties believed to help mitigate depression. The conversation highlights EPA’s unique mechanism compared to typical omega‑3 benefits and suggests it may be a promising adjunctive treatment for depression by targeting inflammation.










